Nocturia is an independent predictive factor of prevalent hypertension in obstructive sleep apnea patients Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters Year: 2014
Use of clinical predictors on diagnosis of OSAS in patients with chronic obstructive pulmonary disease, asthma and cardiovascular diseases Source: International Congress 2014 – Sleep disordered breathing 3 Year: 2014
Sleep disordered breathing in patients with cardiovascular comorbidities hospitalized for pulmonary disease Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults I: questionnaires, epidemiology and sleep studies Year: 2015
Cumulative association of OSA severity and sleep dept with hypertension Source: International Congress 2014 – Real or not? The impact of OSA and CPAP on comorbid conditions Year: 2014
Impacts of long-term CPAP therapy on fatty liver in male OSA patients with abdominal obesity Source: International Congress 2014 – Real or not? The impact of OSA and CPAP on comorbid conditions Year: 2014
The clinical presentation of obstructive sleep apnea syndrome is different in diabetic patients Source: International Congress 2016 – Effect of sleep apnoea on life-span and comorbidities Year: 2016
Prevalence of obstructive sleep apnea syndrome in patients with risk factors for cardiovascular diseases in a large population in Zaragoza (Spain) Source: International Congress 2014 – Sleep disordered breathing 3 Year: 2014
Predictors of nocturnal hypertension in obstructive sleep apnea patients with metabolic syndrome Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013
Protective cardiovascular effect of sleep apnea severity in obesity hypoventilation syndrome Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels Year: 2016
Prevalence and predictive factors of sleep breathing disorders (SBD) in severe COPD patients Source: International Congress 2014 – Sleep disordered breathing 2 Year: 2014
Smoking status, clinical presentation and outcomes in obstructive sleep apnoea Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters Year: 2014
Determinants of subclinical atherosclerosis in patients with obstructive sleep apnoea Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults III: questionnaires, epidemiology and sleep studies Year: 2015
Erythrocytosis in patients with obstructive sleep apnea Source: International Congress 2014 – Sleep disordered breathing 1 Year: 2014
Progression of subclinical atherosclerosis in obstructive sleep apnoea (OSA) Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels Year: 2016
Prevalence of hyperuricemia in patients with obstructive sleep apnea from the Mallorca cohort Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters Year: 2014
Weight changes in patients with obstructive sleep apnoea syndrome (OSAS) before and after CPAP Source: International Congress 2014 – Sleep disordered breathing: from children to the elderly Year: 2014
Prevalence of sleep-disordered breathing related symptoms and results from an objective vigilance test in patients with chronic heart failure Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing Year: 2013
Prevalence of metabolic syndrome with obstructive sleep apnea in a Korean population Source: Annual Congress 2013 –Sleep disordered breathing in special situations III Year: 2013
Multimorbidity is a risk factor for obstructive sleep apnea-hypopnea syndrome in ageing Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults I: questionnaires, epidemiology and sleep studies Year: 2015
Predictors of increased daytime sleepiness in patients with COPD Source: International Congress 2014 – Sleep disordered breathing 2 Year: 2014